GSK to post all clinical trial information on drugs it sells

06/20/2004 |

GlaxoSmithKline, widely criticized for its handling of information about its major antidepressant drug, Paxil, announced it will post clinical trials results for all its marketed drugs on a company Web site. GSK said the site will include results of all tests run on a drug before its approval, as well as any additional tests devised for new uses after a drug goes to market. Last week, the company posted on its site all test reports on Paxil and its effect on children and adolescents, including indications it caused suicidal tendencies in some patients, and indicated it would expand the move to include other drugs.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA